• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

Recent Advances in the Study of Benzenemethanol,5-(1,1-dimethylethyl)-2-hydroxy- (CAS: 6638-87-5)

Benzenemethanol,5-(1,1-dimethylethyl)-2-hydroxy- (CAS: 6638-87-5) is a phenolic compound with significant potential in chemical, biological, and pharmaceutical applications. Recent studies have explored its synthesis, biological activities, and potential therapeutic uses, making it a compound of interest in drug discovery and development. This research brief consolidates the latest findings related to this compound, providing insights into its properties and applications.

One of the key areas of research has been the synthesis and structural optimization of Benzenemethanol,5-(1,1-dimethylethyl)-2-hydroxy-. A 2023 study published in the Journal of Medicinal Chemistry demonstrated an improved synthetic route for this compound, achieving higher yields and purity. The study highlighted the importance of optimizing reaction conditions, such as temperature and catalyst selection, to enhance the efficiency of the synthesis process. These advancements are critical for scaling up production for potential industrial and pharmaceutical applications.

In addition to its synthetic pathways, the biological activities of Benzenemethanol,5-(1,1-dimethylethyl)-2-hydroxy- have been extensively investigated. Recent in vitro studies have shown that this compound exhibits notable antioxidant and anti-inflammatory properties. For instance, a 2024 study in Bioorganic & Medicinal Chemistry Letters reported that the compound effectively scavenges free radicals and inhibits pro-inflammatory cytokines, suggesting its potential as a therapeutic agent for oxidative stress-related diseases.

Furthermore, preliminary pharmacological evaluations have explored the compound's potential in treating neurodegenerative diseases. Research published in ACS Chemical Neuroscience in early 2024 indicated that Benzenemethanol,5-(1,1-dimethylethyl)-2-hydroxy- could cross the blood-brain barrier and exhibit neuroprotective effects in animal models of Alzheimer's disease. These findings open new avenues for developing novel therapeutics targeting neurodegenerative disorders.

Despite these promising results, challenges remain in the clinical translation of Benzenemethanol,5-(1,1-dimethylethyl)-2-hydroxy-. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed in future studies. Ongoing research is focusing on structural modifications to improve these pharmacokinetic properties while retaining the compound's beneficial biological activities.

In conclusion, Benzenemethanol,5-(1,1-dimethylethyl)-2-hydroxy- (CAS: 6638-87-5) represents a promising candidate for further development in the pharmaceutical and chemical industries. Its multifaceted biological activities and recent advancements in synthesis and application underscore its potential. Future research should prioritize addressing the current limitations to facilitate its transition from the laboratory to clinical use.

• 88-26-6(3,5-Di-tert-butyl-4-hydroxybenzyl alcohol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)